Landscape Analysis of Amyotrophic Lateral Sclerosis

Download and get full access to the new AdisInsight report

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — those nerve cells in the brain and spinal cord that control voluntary muscle movement. As motor neurons degenerate and die, they stop sending messages to the muscles, which causes the muscles to weaken, start to twitch (fasciculations), and waste away (atrophy). Eventually, the brain loses its ability to initiate and control voluntary movements. In this report, we will explore the available treatment options and the ALS landscape.

Download the full report for free now

Drawing from data and intelligence found in our database, our report aims to analyze the landscape of ALS drug development marked by significant and promising advancements, including:

  • Global ALS drug distribution analysis
  • Marketed and Approved drugs
  • Geographical distribution of drugs in late-stage clinical development and much more

Why AdisInsight?

AdisInsight can help you stay informed about drugs in development, identify investment opportunities, gain competitive advantage and increase efficiency.

Get a global perspective of the most compelling current evidence driving drug development:

Knowledge and expertise

You can rely on our extensive knowledge and expertise, earned over 40 years as an industry leader. Our experience gives us a unique perspective on the challenges you face today, helping you see the world of drug development more clearly. Our data is vetted, validated, and given context by human experts – the additional layer of review that gives you unparalleled value. We curate, monitor and partner with reliable and reputable data sources, giving you complete confidence in the accuracy of data.

Smarter strategic decisions

We are pioneers and experts in providing rich, reliable, high-quality data solutions that give you the trustworthy insights you need to make smarter strategic decisions. Avoid missing out on crucial data insights that could be the difference between achieving core goals and watching competitors get ahead. Explore commercial opportunities, competitor insights, investment possibilities, and drug development opportunities with a single view of the drug landscape.

Data you can trust

Our philosophy is that accurate data is your most important asset. The risks of acting too quickly on incomplete or unreliable data are enormous, which is why we dedicate time to carefully validate and structure the data you rely on to drive strategic decision making. We’re transparent around where our data comes from, how we validate it, and how we add context. This gives you data you can trust, so all stakeholders can act with complete confidence.